CVKD Earnings

Quarterly EPS
$-2.18
Q3 2024
$-2.55
Q4 2024
$-2.09
Q1 2025
$-1.87
Q2 2025
$-1.31
Q3 2025
$-1.43
Q4 2025
$-1.04
Q1 2026
$-1.14
Q2 2026
Latest RevenueN/A
Latest Net Income-3322565
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.140-3322565+39.0%
Q1 2026-$1.040-2496540+50.2%
Q4 2025-$1.430-3038990+43.9%
Q3 2025-$1.310-2685705+39.9%
Q2 2025-$1.870-3667287+16.5%
Q1 2025-$2.090-3845380-34.0%
Q4 2024-$2.550-4187269-355.4%
Q3 2024-$2.180-2407829-115.8%
Q2 2024-$2.240-2392982
Q1 2024-$1.560-1663288
Q4 2023-$0.560-1144060
Q3 2023-$1.010-1036451
Cadrenal Therapeutics (CVKD) — Earnings